

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 8.34719354 |
| 2 | desmosome organization (GO:0002934) | 7.93213701 |
| 3 | surfactant homeostasis (GO:0043129) | 7.27579972 |
| 4 | cilium or flagellum-dependent cell motility (GO:0001539) | 6.56110778 |
| 5 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.23653481 |
| 6 | lung epithelium development (GO:0060428) | 5.87988690 |
| 7 | chemical homeostasis within a tissue (GO:0048875) | 5.78991066 |
| 8 | motile cilium assembly (GO:0044458) | 5.77365749 |
| 9 | cilium movement (GO:0003341) | 5.68417632 |
| 10 | hemidesmosome assembly (GO:0031581) | 5.38267008 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.34261853 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 5.34261853 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.25804304 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 5.25804304 |
| 15 | vitamin transmembrane transport (GO:0035461) | 5.09509312 |
| 16 | cysteine metabolic process (GO:0006534) | 5.01381428 |
| 17 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.89239970 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 4.86526836 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.86043801 |
| 20 | regulation of water loss via skin (GO:0033561) | 4.75519099 |
| 21 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.74698495 |
| 22 | epithelial cilium movement (GO:0003351) | 4.73653623 |
| 23 | * multicellular organismal water homeostasis (GO:0050891) | 4.70214044 |
| 24 | drug catabolic process (GO:0042737) | 4.65873041 |
| 25 | O-glycan processing (GO:0016266) | 4.64529904 |
| 26 | establishment of apical/basal cell polarity (GO:0035089) | 4.62171053 |
| 27 | diterpenoid biosynthetic process (GO:0016102) | 4.59659861 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 4.58002714 |
| 29 | tryptophan catabolic process (GO:0006569) | 4.58002714 |
| 30 | indole-containing compound catabolic process (GO:0042436) | 4.58002714 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 4.57264308 |
| 32 | establishment of skin barrier (GO:0061436) | 4.51776013 |
| 33 | ethanol oxidation (GO:0006069) | 4.51479791 |
| 34 | glyoxylate metabolic process (GO:0046487) | 4.50800517 |
| 35 | lysine catabolic process (GO:0006554) | 4.43239485 |
| 36 | lysine metabolic process (GO:0006553) | 4.43239485 |
| 37 | kynurenine metabolic process (GO:0070189) | 4.40670556 |
| 38 | exogenous drug catabolic process (GO:0042738) | 4.34879651 |
| 39 | tryptophan metabolic process (GO:0006568) | 4.32151098 |
| 40 | keratinocyte proliferation (GO:0043616) | 4.24413197 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.14271938 |
| 42 | alpha-linolenic acid metabolic process (GO:0036109) | 4.12766801 |
| 43 | urate metabolic process (GO:0046415) | 4.11223236 |
| 44 | intestinal epithelial cell development (GO:0060576) | 4.11125662 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.09793479 |
| 46 | hormone catabolic process (GO:0042447) | 4.01550430 |
| 47 | negative regulation of fibrinolysis (GO:0051918) | 3.98209300 |
| 48 | phosphate ion transmembrane transport (GO:0035435) | 3.98097116 |
| 49 | glomerular epithelial cell development (GO:0072310) | 3.97465284 |
| 50 | drug transmembrane transport (GO:0006855) | 3.94856932 |
| 51 | bile acid biosynthetic process (GO:0006699) | 3.93741789 |
| 52 | epithelial cell-cell adhesion (GO:0090136) | 3.91286187 |
| 53 | drug metabolic process (GO:0017144) | 3.89197701 |
| 54 | response to xenobiotic stimulus (GO:0009410) | 3.85350826 |
| 55 | protein carboxylation (GO:0018214) | 3.85048879 |
| 56 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.85048879 |
| 57 | * water homeostasis (GO:0030104) | 3.84942810 |
| 58 | establishment of planar polarity (GO:0001736) | 3.84167538 |
| 59 | establishment of tissue polarity (GO:0007164) | 3.84167538 |
| 60 | flavonoid metabolic process (GO:0009812) | 3.83429232 |
| 61 | phosphate ion transport (GO:0006817) | 3.83202027 |
| 62 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.81000661 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 3.79852449 |
| 64 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.79700657 |
| 65 | establishment of monopolar cell polarity (GO:0061162) | 3.79700657 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 3.76172959 |
| 67 | urea cycle (GO:0000050) | 3.73173740 |
| 68 | urea metabolic process (GO:0019627) | 3.73173740 |
| 69 | regulation of cholesterol homeostasis (GO:2000188) | 3.72350332 |
| 70 | complement activation, alternative pathway (GO:0006957) | 3.69302884 |
| 71 | ethanol metabolic process (GO:0006067) | 3.64345276 |
| 72 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.63509725 |
| 73 | response to mercury ion (GO:0046689) | 3.63448645 |
| 74 | terpenoid biosynthetic process (GO:0016114) | 3.56900811 |
| 75 | xenobiotic catabolic process (GO:0042178) | 3.55780844 |
| 76 | tight junction assembly (GO:0070830) | 3.54522119 |
| 77 | regulation of protein activation cascade (GO:2000257) | 3.53676226 |
| 78 | one-carbon compound transport (GO:0019755) | 3.52234056 |
| 79 | axoneme assembly (GO:0035082) | 3.52104299 |
| 80 | regulation of fibrinolysis (GO:0051917) | 3.51419527 |
| 81 | serine family amino acid catabolic process (GO:0009071) | 3.51005560 |
| 82 | coenzyme catabolic process (GO:0009109) | 3.50510843 |
| 83 | aromatic amino acid family metabolic process (GO:0009072) | 3.46097640 |
| 84 | nitrogen cycle metabolic process (GO:0071941) | 3.41739457 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 3.41715341 |
| 86 | lateral sprouting from an epithelium (GO:0060601) | 3.41301127 |
| 87 | regulation of complement activation (GO:0030449) | 3.41277868 |
| 88 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.40994205 |
| 89 | gap junction assembly (GO:0016264) | 3.40714725 |
| 90 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.40304301 |
| 91 | primary alcohol catabolic process (GO:0034310) | 3.34244005 |
| 92 | bile acid metabolic process (GO:0008206) | 3.32800113 |
| 93 | oligosaccharide biosynthetic process (GO:0009312) | 3.32249609 |
| 94 | retinoic acid metabolic process (GO:0042573) | 3.29687659 |
| 95 | response to nitrosative stress (GO:0051409) | 3.29515937 |
| 96 | drug transport (GO:0015893) | 3.27861494 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.27739655 |
| 98 | glutamate metabolic process (GO:0006536) | 3.26136429 |
| 99 | alpha-amino acid catabolic process (GO:1901606) | 3.24790143 |
| 100 | L-ascorbic acid metabolic process (GO:0019852) | 3.24424718 |
| 101 | regulation of keratinocyte proliferation (GO:0010837) | 3.23788767 |
| 102 | apical protein localization (GO:0045176) | 3.23128488 |
| 103 | * excretion (GO:0007588) | 3.22526919 |
| 104 | high-density lipoprotein particle remodeling (GO:0034375) | 3.18526268 |
| 105 | cellular amino acid catabolic process (GO:0009063) | 3.18358717 |
| 106 | left/right pattern formation (GO:0060972) | 3.17614815 |
| 107 | negative regulation of cholesterol transport (GO:0032375) | 3.17214524 |
| 108 | negative regulation of sterol transport (GO:0032372) | 3.17214524 |
| 109 | fatty acid oxidation (GO:0019395) | 3.16908239 |
| 110 | fatty acid beta-oxidation (GO:0006635) | 3.16515954 |
| 111 | sodium-independent organic anion transport (GO:0043252) | 3.13404271 |
| 112 | indolalkylamine metabolic process (GO:0006586) | 3.12081960 |
| 113 | keratinization (GO:0031424) | 3.10285451 |
| 114 | lipid oxidation (GO:0034440) | 3.10187488 |
| 115 | carnitine metabolic process (GO:0009437) | 3.08977063 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.08729808 |
| 117 | protein O-linked glycosylation (GO:0006493) | 3.05650303 |
| 118 | tyrosine metabolic process (GO:0006570) | 3.05329885 |
| 119 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.02711215 |
| 120 | peptide catabolic process (GO:0043171) | 2.99553035 |
| 121 | cellular ketone body metabolic process (GO:0046950) | 2.99048641 |
| 122 | sphingomyelin metabolic process (GO:0006684) | 2.98796006 |
| 123 | serine family amino acid metabolic process (GO:0009069) | 2.98585368 |
| 124 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.96493027 |
| 125 | trivalent inorganic anion homeostasis (GO:0072506) | 2.95880973 |
| 126 | phosphate ion homeostasis (GO:0055062) | 2.95880973 |
| 127 | valine metabolic process (GO:0006573) | 2.95858887 |
| 128 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.93845816 |
| 129 | acetyl-CoA metabolic process (GO:0006084) | 2.93725616 |
| 130 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.91512742 |
| 131 | imidazole-containing compound metabolic process (GO:0052803) | 2.91215167 |
| 132 | sulfate transmembrane transport (GO:1902358) | 2.90443975 |
| 133 | aspartate family amino acid catabolic process (GO:0009068) | 2.90009023 |
| 134 | regulation of triglyceride catabolic process (GO:0010896) | 2.89689217 |
| 135 | intestinal absorption (GO:0050892) | 2.88726324 |
| 136 | NADP metabolic process (GO:0006739) | 2.86992595 |
| 137 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.86589354 |
| 138 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.86589354 |
| 139 | primary alcohol metabolic process (GO:0034308) | 2.86494816 |
| 140 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.86482642 |
| 141 | cellular biogenic amine catabolic process (GO:0042402) | 2.86203549 |
| 142 | amine catabolic process (GO:0009310) | 2.86203549 |
| 143 | carboxylic acid catabolic process (GO:0046395) | 2.86161840 |
| 144 | organic acid catabolic process (GO:0016054) | 2.86161840 |
| 145 | glutathione derivative biosynthetic process (GO:1901687) | 2.85528014 |
| 146 | glutathione derivative metabolic process (GO:1901685) | 2.85528014 |
| 147 | cellular glucuronidation (GO:0052695) | 2.85262564 |
| 148 | fatty acid catabolic process (GO:0009062) | 2.84008608 |
| 149 | transepithelial transport (GO:0070633) | 2.83861257 |
| 150 | omega-hydroxylase P450 pathway (GO:0097267) | 2.83848034 |
| 151 | aldehyde catabolic process (GO:0046185) | 2.83352247 |
| 152 | bile acid and bile salt transport (GO:0015721) | 2.82894212 |
| 153 | monocarboxylic acid catabolic process (GO:0072329) | 2.81614339 |
| 154 | cell-cell junction assembly (GO:0007043) | 2.81155007 |
| 155 | regulation of endothelial cell differentiation (GO:0045601) | 2.81053753 |
| 156 | renal absorption (GO:0070293) | 2.79922033 |
| 157 | semaphorin-plexin signaling pathway (GO:0071526) | 2.79761431 |
| 158 | thyroid hormone generation (GO:0006590) | 2.78399505 |
| 159 | protein autoprocessing (GO:0016540) | 2.78391230 |
| 160 | 2-oxoglutarate metabolic process (GO:0006103) | 2.78249922 |
| 161 | retinol metabolic process (GO:0042572) | 2.77875885 |
| 162 | sperm capacitation (GO:0048240) | 2.76751382 |
| 163 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.76704081 |
| 164 | triglyceride homeostasis (GO:0070328) | 2.76307894 |
| 165 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.75637648 |
| 166 | regulation of ruffle assembly (GO:1900027) | 2.74628451 |
| 167 | asymmetric protein localization (GO:0008105) | 2.74432023 |
| 168 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.73839777 |
| 169 | polarized epithelial cell differentiation (GO:0030859) | 2.67676421 |
| 170 | renal system development (GO:0072001) | 2.66485882 |
| 171 | keratinocyte differentiation (GO:0030216) | 2.65486788 |
| 172 | transcytosis (GO:0045056) | 2.63125001 |
| 173 | glutathione biosynthetic process (GO:0006750) | 2.62308374 |
| 174 | muscle cell migration (GO:0014812) | 2.61729940 |
| 175 | amyloid precursor protein catabolic process (GO:0042987) | 2.59023001 |
| 176 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.57812086 |
| 177 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.56076991 |
| 178 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.54608033 |
| 179 | embryonic camera-type eye development (GO:0031076) | 2.53737659 |
| 180 | collecting duct development (GO:0072044) | 2.53224517 |
| 181 | epidermis development (GO:0008544) | 2.52603414 |
| 182 | epidermal cell differentiation (GO:0009913) | 2.51677899 |
| 183 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.47295409 |
| 184 | thyroid hormone metabolic process (GO:0042403) | 2.46820613 |
| 185 | lung secretory cell differentiation (GO:0061140) | 2.46355733 |
| 186 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.46144512 |
| 187 | sulfur compound transport (GO:0072348) | 2.45531966 |
| 188 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.44845827 |
| 189 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.44592794 |
| 190 | renal filtration (GO:0097205) | 2.44544802 |
| 191 | glucuronate metabolic process (GO:0019585) | 2.43961049 |
| 192 | uronic acid metabolic process (GO:0006063) | 2.43961049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.01491808 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.30230654 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.68486007 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.38577713 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.32392788 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.43061011 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.25398535 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.05617986 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.00769004 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.77996245 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.54252261 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.50436710 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46537920 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.41000758 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.38709707 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.32841333 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.24039673 |
| 18 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.03742410 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00225999 |
| 20 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.95408273 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.90700426 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71768033 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70505570 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63396541 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63254449 |
| 26 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.61767850 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61543418 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.57938567 |
| 29 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.56247934 |
| 30 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.52935443 |
| 31 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.51894272 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48865120 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48863762 |
| 34 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48384924 |
| 35 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43579215 |
| 36 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.43088559 |
| 37 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.42001107 |
| 38 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.40781805 |
| 39 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.39980768 |
| 40 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.39366529 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37503690 |
| 42 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.36314336 |
| 43 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35830468 |
| 44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32598685 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31489613 |
| 46 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.29377094 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28695550 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28641683 |
| 49 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.25684448 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25546021 |
| 51 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24600239 |
| 52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21334504 |
| 53 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.20065382 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19906324 |
| 55 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16881317 |
| 56 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.16370207 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.15490800 |
| 58 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14353525 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.14047215 |
| 60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12813605 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12518190 |
| 62 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12503284 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10784344 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10177078 |
| 65 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09862043 |
| 66 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09848219 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09003820 |
| 68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08044725 |
| 69 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07846518 |
| 70 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07182500 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06484555 |
| 72 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06384657 |
| 73 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.06282412 |
| 74 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.06282412 |
| 75 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.06282412 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05806656 |
| 77 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05496815 |
| 78 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04886401 |
| 79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.04853321 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04739910 |
| 81 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03543220 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03222735 |
| 83 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02752683 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01367605 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01294648 |
| 86 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99816102 |
| 87 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99471436 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99350768 |
| 89 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.98332889 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97905084 |
| 91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97327081 |
| 92 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97185047 |
| 93 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97185047 |
| 94 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95101934 |
| 95 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94831814 |
| 96 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.94227220 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94137763 |
| 98 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.90636198 |
| 99 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.90387086 |
| 100 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90093631 |
| 101 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89884286 |
| 102 | SA1_27219007_Chip-Seq_Bcells_Human | 0.88650215 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88537975 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.88494648 |
| 105 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.87514541 |
| 106 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87052213 |
| 107 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.86698650 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84771028 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84704870 |
| 110 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84269681 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84126757 |
| 112 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.83684476 |
| 113 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.83184988 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82553850 |
| 115 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82430764 |
| 116 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.82271513 |
| 117 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.81781349 |
| 118 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.81478437 |
| 119 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.81477235 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81072851 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79987972 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78063600 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.77919746 |
| 124 | ATF3_27146783_Chip-Seq_COLON_Human | 0.77608640 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77544629 |
| 126 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76187961 |
| 127 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75401331 |
| 128 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75401331 |
| 129 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74896474 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.73719899 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.73558383 |
| 132 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.73546487 |
| 133 | KDM2B_26808549_Chip-Seq_K562_Human | 0.72432269 |
| 134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71460604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.91466908 |
| 2 | MP0005360_urolithiasis | 5.53974366 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93038575 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.20071547 |
| 5 | MP0005365_abnormal_bile_salt | 3.94929376 |
| 6 | MP0004782_abnormal_surfactant_physiolog | 3.77439539 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.53655620 |
| 8 | MP0003941_abnormal_skin_development | 2.93668304 |
| 9 | MP0005083_abnormal_biliary_tract | 2.82323180 |
| 10 | MP0005377_hearing/vestibular/ear_phenot | 2.77138828 |
| 11 | MP0003878_abnormal_ear_physiology | 2.77138828 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.69316745 |
| 13 | MP0003252_abnormal_bile_duct | 2.62918885 |
| 14 | MP0001958_emphysema | 2.55599211 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.53566413 |
| 16 | MP0005332_abnormal_amino_acid | 2.49177806 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.39040568 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 2.38227211 |
| 19 | MP0010368_abnormal_lymphatic_system | 2.31163594 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.18499050 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.15834851 |
| 22 | MP0000467_abnormal_esophagus_morphology | 2.14816736 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 2.05110817 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.00807632 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.99131599 |
| 26 | MP0010030_abnormal_orbit_morphology | 1.90179330 |
| 27 | MP0009840_abnormal_foam_cell | 1.90046560 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.82105800 |
| 29 | MP0000762_abnormal_tongue_morphology | 1.80410457 |
| 30 | MP0005167_abnormal_blood-brain_barrier | 1.80058285 |
| 31 | MP0004043_abnormal_pH_regulation | 1.77834165 |
| 32 | MP0002132_abnormal_respiratory_system | 1.77770574 |
| 33 | MP0003195_calcinosis | 1.73010225 |
| 34 | MP0002254_reproductive_system_inflammat | 1.69024788 |
| 35 | MP0002796_impaired_skin_barrier | 1.63984598 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.56914674 |
| 37 | MP0004264_abnormal_extraembryonic_tissu | 1.55265451 |
| 38 | MP0008004_abnormal_stomach_pH | 1.51725867 |
| 39 | MP0001756_abnormal_urination | 1.50361982 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.48933116 |
| 41 | MP0000609_abnormal_liver_physiology | 1.47971060 |
| 42 | MP0004133_heterotaxia | 1.41234967 |
| 43 | MP0001765_abnormal_ion_homeostasis | 1.36707299 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 1.36581546 |
| 45 | MP0003724_increased_susceptibility_to | 1.35916554 |
| 46 | MP0010771_integument_phenotype | 1.34104373 |
| 47 | MP0002653_abnormal_ependyma_morphology | 1.33670572 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.30851412 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.27313391 |
| 50 | MP0009764_decreased_sensitivity_to | 1.26227971 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.25123779 |
| 52 | MP0005409_darkened_coat_color | 1.24411954 |
| 53 | MP0008995_early_reproductive_senescence | 1.23530128 |
| 54 | MP0001664_abnormal_digestion | 1.23507249 |
| 55 | * MP0002136_abnormal_kidney_physiology | 1.22104936 |
| 56 | MP0000477_abnormal_intestine_morphology | 1.20049914 |
| 57 | MP0001879_abnormal_lymphatic_vessel | 1.18586468 |
| 58 | MP0002098_abnormal_vibrissa_morphology | 1.18192097 |
| 59 | MP0002249_abnormal_larynx_morphology | 1.17291396 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16441847 |
| 61 | MP0004858_abnormal_nervous_system | 1.14882395 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.14597668 |
| 63 | MP0003186_abnormal_redox_activity | 1.13091133 |
| 64 | MP0001188_hyperpigmentation | 1.11421711 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.04775780 |
| 66 | MP0009379_abnormal_foot_pigmentation | 1.04294354 |
| 67 | MP0001177_atelectasis | 1.01437732 |
| 68 | MP0003119_abnormal_digestive_system | 1.01190934 |
| 69 | MP0008961_abnormal_basal_metabolism | 0.99881707 |
| 70 | MP0008789_abnormal_olfactory_epithelium | 0.99579095 |
| 71 | MP0004272_abnormal_basement_membrane | 0.98666264 |
| 72 | MP0002133_abnormal_respiratory_system | 0.98608938 |
| 73 | MP0005388_respiratory_system_phenotype | 0.98608938 |
| 74 | MP0001485_abnormal_pinna_reflex | 0.97402467 |
| 75 | MP0010678_abnormal_skin_adnexa | 0.96066463 |
| 76 | MP0000627_abnormal_mammary_gland | 0.94833901 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 0.94750319 |
| 78 | MP0002909_abnormal_adrenal_gland | 0.93599403 |
| 79 | MP0003693_abnormal_embryo_hatching | 0.92056289 |
| 80 | MP0002295_abnormal_pulmonary_circulatio | 0.91713603 |
| 81 | MP0005670_abnormal_white_adipose | 0.90028710 |
| 82 | MP0005408_hypopigmentation | 0.86989414 |
| 83 | MP0003937_abnormal_limbs/digits/tail_de | 0.86175950 |
| 84 | MP0005275_abnormal_skin_tensile | 0.85976650 |
| 85 | MP0002089_abnormal_postnatal_growth/wei | 0.84885400 |
| 86 | MP0003075_altered_response_to | 0.84292668 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.83461368 |
| 88 | MP0003868_abnormal_feces_composition | 0.83349102 |
| 89 | MP0005023_abnormal_wound_healing | 0.83246239 |
| 90 | MP0005501_abnormal_skin_physiology | 0.83137951 |
| 91 | MP0002876_abnormal_thyroid_physiology | 0.81898402 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.81046635 |
| 93 | MP0000470_abnormal_stomach_morphology | 0.80905383 |
| 94 | MP0005164_abnormal_response_to | 0.79528307 |
| 95 | MP0000537_abnormal_urethra_morphology | 0.78539993 |
| 96 | MP0000681_abnormal_thyroid_gland | 0.77966774 |
| 97 | MP0003638_abnormal_response/metabolism_ | 0.77864460 |
| 98 | MP0004883_abnormal_blood_vessel | 0.77323464 |
| 99 | MP0005647_abnormal_sex_gland | 0.76770794 |
| 100 | MP0002168_other_aberrant_phenotype | 0.76730537 |
| 101 | MP0000598_abnormal_liver_morphology | 0.75045655 |
| 102 | MP0002111_abnormal_tail_morphology | 0.74858110 |
| 103 | MP0005166_decreased_susceptibility_to | 0.74238804 |
| 104 | MP0005395_other_phenotype | 0.73985267 |
| 105 | MP0009931_abnormal_skin_appearance | 0.73887275 |
| 106 | MP0003890_abnormal_embryonic-extraembry | 0.72685273 |
| 107 | MP0003011_delayed_dark_adaptation | 0.72577004 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.72272942 |
| 109 | MP0010155_abnormal_intestine_physiology | 0.71198465 |
| 110 | MP0000343_altered_response_to | 0.70023157 |
| 111 | MP0005451_abnormal_body_composition | 0.69490273 |
| 112 | MP0000249_abnormal_blood_vessel | 0.69377770 |
| 113 | MP0001346_abnormal_lacrimal_gland | 0.68838376 |
| 114 | MP0003938_abnormal_ear_development | 0.67291970 |
| 115 | MP0002135_abnormal_kidney_morphology | 0.66569652 |
| 116 | MP0001216_abnormal_epidermal_layer | 0.66474605 |
| 117 | MP0001764_abnormal_homeostasis | 0.66337230 |
| 118 | MP0003115_abnormal_respiratory_system | 0.66162469 |
| 119 | MP0002282_abnormal_trachea_morphology | 0.66070441 |
| 120 | MP0008469_abnormal_protein_level | 0.65234928 |
| 121 | MP0001849_ear_inflammation | 0.65129924 |
| 122 | MP0003866_abnormal_defecation | 0.64717035 |
| 123 | MP0000383_abnormal_hair_follicle | 0.64183610 |
| 124 | MP0002233_abnormal_nose_morphology | 0.63859560 |
| 125 | MP0000566_synostosis | 0.63155476 |
| 126 | MP0003315_abnormal_perineum_morphology | 0.62637621 |
| 127 | MP0000490_abnormal_crypts_of | 0.62105771 |
| 128 | * MP0009642_abnormal_blood_homeostasis | 0.61996930 |
| 129 | MP0002060_abnormal_skin_morphology | 0.59703641 |
| 130 | MP0002697_abnormal_eye_size | 0.59431566 |
| 131 | MP0003436_decreased_susceptibility_to | 0.59020303 |
| 132 | MP0005376_homeostasis/metabolism_phenot | 0.58385234 |
| 133 | MP0000377_abnormal_hair_follicle | 0.58345926 |
| 134 | MP0005394_taste/olfaction_phenotype | 0.57602291 |
| 135 | MP0005499_abnormal_olfactory_system | 0.57602291 |
| 136 | MP0001984_abnormal_olfaction | 0.56657731 |
| 137 | MP0000432_abnormal_head_morphology | 0.56123212 |
| 138 | MP0000678_abnormal_parathyroid_gland | 0.55722428 |
| 139 | MP0002084_abnormal_developmental_patter | 0.55700628 |
| 140 | MP0000579_abnormal_nail_morphology | 0.55008973 |
| 141 | MP0000604_amyloidosis | 0.54510753 |
| 142 | MP0009765_abnormal_xenobiotic_induced | 0.53799393 |
| 143 | MP0003329_amyloid_beta_deposits | 0.53009403 |
| 144 | MP0005220_abnormal_exocrine_pancreas | 0.51783071 |
| 145 | MP0009384_cardiac_valve_regurgitation | 0.51542334 |
| 146 | MP0004947_skin_inflammation | 0.51274866 |
| 147 | MP0004885_abnormal_endolymph | 0.50951524 |
| 148 | MP0009763_increased_sensitivity_to | 0.50427808 |
| 149 | MP0005165_increased_susceptibility_to | 0.48259253 |
| 150 | MP0000462_abnormal_digestive_system | 0.46744774 |
| 151 | MP0009053_abnormal_anal_canal | 0.45976512 |
| 152 | MP0005595_abnormal_vascular_smooth | 0.45162204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 7.40658837 |
| 2 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.39274232 |
| 3 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.39274232 |
| 4 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.18152333 |
| 5 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.07725904 |
| 6 | Absent/shortened dynein arms (HP:0200106) | 6.07725904 |
| 7 | Abnormal ciliary motility (HP:0012262) | 5.91309758 |
| 8 | * Chronic bronchitis (HP:0004469) | 5.86426133 |
| 9 | Rhinitis (HP:0012384) | 5.80686207 |
| 10 | Gout (HP:0001997) | 5.68948856 |
| 11 | Interstitial pulmonary disease (HP:0006530) | 5.50967328 |
| 12 | Deep venous thrombosis (HP:0002625) | 5.34330096 |
| 13 | * Hyperactive renin-angiotensin system (HP:0000841) | 5.15724002 |
| 14 | Hypokalemic alkalosis (HP:0001949) | 4.64094979 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.57732626 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 4.54191920 |
| 17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.44496721 |
| 18 | * Bronchiectasis (HP:0002110) | 4.32932363 |
| 19 | Pili torti (HP:0003777) | 3.97235422 |
| 20 | Xanthomatosis (HP:0000991) | 3.91111925 |
| 21 | Polycythemia (HP:0001901) | 3.84025851 |
| 22 | Nasal polyposis (HP:0100582) | 3.81497354 |
| 23 | Hyperglycinuria (HP:0003108) | 3.72186235 |
| 24 | Alkalosis (HP:0001948) | 3.71946426 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.69729133 |
| 26 | Abnormality of purine metabolism (HP:0004352) | 3.67136985 |
| 27 | * Renal salt wasting (HP:0000127) | 3.65618581 |
| 28 | * Abnormality of chloride homeostasis (HP:0011422) | 3.59006169 |
| 29 | Complement deficiency (HP:0004431) | 3.52600381 |
| 30 | Esophageal varix (HP:0002040) | 3.46322496 |
| 31 | Tachypnea (HP:0002789) | 3.44764042 |
| 32 | Vascular calcification (HP:0004934) | 3.42705905 |
| 33 | Tubulointerstitial fibrosis (HP:0005576) | 3.38805948 |
| 34 | Increased purine levels (HP:0004368) | 3.34930826 |
| 35 | Hyperuricemia (HP:0002149) | 3.34930826 |
| 36 | Lip pit (HP:0100267) | 3.24808172 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.23205190 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.23205190 |
| 39 | Metabolic alkalosis (HP:0200114) | 3.15879421 |
| 40 | Hyperammonemia (HP:0001987) | 3.14410221 |
| 41 | Ketosis (HP:0001946) | 3.14339787 |
| 42 | Abnormal hair laboratory examination (HP:0003328) | 3.13575848 |
| 43 | Joint hemorrhage (HP:0005261) | 3.11912818 |
| 44 | Plantar hyperkeratosis (HP:0007556) | 3.11049716 |
| 45 | Cardiovascular calcification (HP:0011915) | 3.06317262 |
| 46 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05452660 |
| 47 | Prolonged partial thromboplastin time (HP:0003645) | 3.01351788 |
| 48 | Flat acetabular roof (HP:0003180) | 2.98208782 |
| 49 | Onycholysis (HP:0001806) | 2.95761206 |
| 50 | Malnutrition (HP:0004395) | 2.95182138 |
| 51 | Hyperlipoproteinemia (HP:0010980) | 2.92553645 |
| 52 | Hypobetalipoproteinemia (HP:0003563) | 2.90292333 |
| 53 | * Hyperaldosteronism (HP:0000859) | 2.87249436 |
| 54 | Abnormality of permanent molar morphology (HP:0011071) | 2.87176169 |
| 55 | Abnormality of the dental root (HP:0006486) | 2.87176169 |
| 56 | Taurodontia (HP:0000679) | 2.87176169 |
| 57 | Fragile nails (HP:0001808) | 2.85291556 |
| 58 | Hyperglycinemia (HP:0002154) | 2.85190149 |
| 59 | Abnormality of renal excretion (HP:0011036) | 2.85039405 |
| 60 | Respiratory distress (HP:0002098) | 2.84867293 |
| 61 | Tubular atrophy (HP:0000092) | 2.81360824 |
| 62 | Visceral angiomatosis (HP:0100761) | 2.80868412 |
| 63 | Abnormality of the nasal mucosa (HP:0000433) | 2.77804665 |
| 64 | Delayed CNS myelination (HP:0002188) | 2.76961439 |
| 65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.72653492 |
| 66 | Milia (HP:0001056) | 2.71412876 |
| 67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.70093259 |
| 68 | Right ventricular cardiomyopathy (HP:0011663) | 2.69781186 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.66797841 |
| 70 | Increased circulating renin level (HP:0000848) | 2.66591018 |
| 71 | Ketoacidosis (HP:0001993) | 2.66486882 |
| 72 | Abnormality of the dental pulp (HP:0006479) | 2.65489317 |
| 73 | Abnormality of the common coagulation pathway (HP:0010990) | 2.63882659 |
| 74 | Tetany (HP:0001281) | 2.62542060 |
| 75 | Male infertility (HP:0003251) | 2.61397961 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.61173988 |
| 77 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.61028348 |
| 78 | Abnormality of molar (HP:0011077) | 2.60658128 |
| 79 | Abnormality of molar morphology (HP:0011070) | 2.60658128 |
| 80 | Alopecia of scalp (HP:0002293) | 2.60486718 |
| 81 | Hemangiomatosis (HP:0007461) | 2.58294675 |
| 82 | Palmoplantar hyperkeratosis (HP:0000972) | 2.56655964 |
| 83 | * Abnormality of renin-angiotensin system (HP:0000847) | 2.55082619 |
| 84 | Fat malabsorption (HP:0002630) | 2.54724451 |
| 85 | Abnormality of complement system (HP:0005339) | 2.53107960 |
| 86 | Abnormal urine output (HP:0012590) | 2.51334022 |
| 87 | Pterygium (HP:0001059) | 2.51299624 |
| 88 | Popliteal pterygium (HP:0009756) | 2.49052124 |
| 89 | Abnormal cartilage morphology (HP:0002763) | 2.48696079 |
| 90 | Hematochezia (HP:0002573) | 2.45867899 |
| 91 | Hypoplasia of dental enamel (HP:0006297) | 2.41171438 |
| 92 | Infertility (HP:0000789) | 2.40128684 |
| 93 | Bronchomalacia (HP:0002780) | 2.37775518 |
| 94 | Palmar hyperkeratosis (HP:0010765) | 2.37399713 |
| 95 | * Bronchitis (HP:0012387) | 2.37070144 |
| 96 | Potter facies (HP:0002009) | 2.36322295 |
| 97 | Facial shape deformation (HP:0011334) | 2.36322295 |
| 98 | Abnormality of the salivary glands (HP:0010286) | 2.36065807 |
| 99 | Proximal tubulopathy (HP:0000114) | 2.35715334 |
| 100 | Hypomagnesemia (HP:0002917) | 2.34136285 |
| 101 | Epidermoid cyst (HP:0200040) | 2.32673322 |
| 102 | Decreased circulating renin level (HP:0003351) | 2.31886312 |
| 103 | Glomerulosclerosis (HP:0000096) | 2.31627056 |
| 104 | Recurrent otitis media (HP:0000403) | 2.26909911 |
| 105 | Amelogenesis imperfecta (HP:0000705) | 2.26826114 |
| 106 | Hepatocellular carcinoma (HP:0001402) | 2.25911910 |
| 107 | Hypolipoproteinemia (HP:0010981) | 2.25658781 |
| 108 | * Metabolic acidosis (HP:0001942) | 2.25200472 |
| 109 | Abnormality of nail color (HP:0100643) | 2.25186004 |
| 110 | Hypoglycemic coma (HP:0001325) | 2.24922640 |
| 111 | Hypoplastic labia majora (HP:0000059) | 2.23962641 |
| 112 | Spastic diplegia (HP:0001264) | 2.16250484 |
| 113 | Absent eyelashes (HP:0000561) | 2.15735223 |
| 114 | Nephrolithiasis (HP:0000787) | 2.15131666 |
| 115 | * Dehydration (HP:0001944) | 2.14946588 |
| 116 | Hypoalphalipoproteinemia (HP:0003233) | 2.14691275 |
| 117 | Tubulointerstitial nephritis (HP:0001970) | 2.14491487 |
| 118 | Cystic liver disease (HP:0006706) | 2.13861526 |
| 119 | Conjugated hyperbilirubinemia (HP:0002908) | 2.13148872 |
| 120 | Focal segmental glomerulosclerosis (HP:0000097) | 2.10926665 |
| 121 | Polyuria (HP:0000103) | 2.10166345 |
| 122 | Rickets (HP:0002748) | 2.09718992 |
| 123 | Hypokalemia (HP:0002900) | 2.09584674 |
| 124 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.09323523 |
| 125 | Hydroxyprolinuria (HP:0003080) | 2.08935971 |
| 126 | Abnormality of proline metabolism (HP:0010907) | 2.08935971 |
| 127 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06643396 |
| 128 | Amyloidosis (HP:0011034) | 2.05189066 |
| 129 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.04286888 |
| 130 | Woolly hair (HP:0002224) | 2.02367681 |
| 131 | Occipital encephalocele (HP:0002085) | 2.00722814 |
| 132 | Ileus (HP:0002595) | 1.99752243 |
| 133 | Atelectasis (HP:0100750) | 1.97541364 |
| 134 | Steatorrhea (HP:0002570) | 1.96734144 |
| 135 | Sparse eyelashes (HP:0000653) | 1.95792082 |
| 136 | Abnormality of the labia majora (HP:0012881) | 1.94868877 |
| 137 | Chronic sinusitis (HP:0011109) | 1.94698329 |
| 138 | Oligodontia (HP:0000677) | 1.94349906 |
| 139 | Generalized aminoaciduria (HP:0002909) | 1.94263784 |
| 140 | Long toe (HP:0010511) | 1.93535471 |
| 141 | * Hyponatremia (HP:0002902) | 1.92007620 |
| 142 | * Hyperkalemia (HP:0002153) | 1.91532928 |
| 143 | Nail dystrophy (HP:0008404) | 1.90804752 |
| 144 | Ulnar bowing (HP:0003031) | 1.90035262 |
| 145 | Hemorrhage of the eye (HP:0011885) | 1.89782138 |
| 146 | Lymphangioma (HP:0100764) | 1.89621879 |
| 147 | Abnormality of magnesium homeostasis (HP:0004921) | 1.89468000 |
| 148 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88182355 |
| 149 | Mitral stenosis (HP:0001718) | 1.87882041 |
| 150 | Recurrent sinusitis (HP:0011108) | 1.87866220 |
| 151 | Dicarboxylic aciduria (HP:0003215) | 1.86658865 |
| 152 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86658865 |
| 153 | Cerebral hemorrhage (HP:0001342) | 1.86130722 |
| 154 | Corneal erosion (HP:0200020) | 1.84760859 |
| 155 | Hypotrichosis (HP:0001006) | 1.83601598 |
| 156 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.83505584 |
| 157 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.83505124 |
| 158 | Aplasia of the phalanges of the hand (HP:0009802) | 1.83505124 |
| 159 | Aplasia involving bones of the extremities (HP:0009825) | 1.83505124 |
| 160 | Hypercholesterolemia (HP:0003124) | 1.83477099 |
| 161 | Chondrocalcinosis (HP:0000934) | 1.83286998 |
| 162 | Abnormality of the lacrimal duct (HP:0011481) | 1.83100642 |
| 163 | Labial hypoplasia (HP:0000066) | 1.81813740 |
| 164 | Advanced eruption of teeth (HP:0006288) | 1.81221427 |
| 165 | Short nail (HP:0001799) | 1.80779532 |
| 166 | Bifid scrotum (HP:0000048) | 1.77363842 |
| 167 | Thick nail (HP:0001805) | 1.76473702 |
| 168 | Abnormality of the nasal septum (HP:0000419) | 1.71120377 |
| 169 | Nasolacrimal duct obstruction (HP:0000579) | 1.70150559 |
| 170 | Hypoplastic female external genitalia (HP:0012815) | 1.68974948 |
| 171 | Abnormality of the gastric mucosa (HP:0004295) | 1.64661532 |
| 172 | Cone-rod dystrophy (HP:0000548) | 1.63594610 |
| 173 | Selective tooth agenesis (HP:0001592) | 1.63378507 |
| 174 | * Abnormality of sodium homeostasis (HP:0010931) | 1.63240568 |
| 175 | Abnormality of the renal medulla (HP:0100957) | 1.61475604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.42005905 |
| 2 | TIE1 | 3.46697026 |
| 3 | TGFBR2 | 3.18710771 |
| 4 | WNK4 | 2.96691881 |
| 5 | FGFR4 | 2.71091537 |
| 6 | LMTK2 | 2.46431749 |
| 7 | OXSR1 | 2.44857540 |
| 8 | BCKDK | 2.44410803 |
| 9 | TRIB3 | 2.30542540 |
| 10 | EPHB1 | 2.26325668 |
| 11 | MST1R | 2.10650403 |
| 12 | LRRK2 | 2.01506128 |
| 13 | EPHA2 | 2.00819538 |
| 14 | NME1 | 1.99952681 |
| 15 | GRK1 | 1.98618419 |
| 16 | SMG1 | 1.92274570 |
| 17 | SIK1 | 1.91485423 |
| 18 | MST4 | 1.85230008 |
| 19 | RIPK1 | 1.83908542 |
| 20 | FGFR2 | 1.83364785 |
| 21 | WNK3 | 1.82568538 |
| 22 | STK10 | 1.74707635 |
| 23 | PTK6 | 1.74020680 |
| 24 | GRK6 | 1.71199092 |
| 25 | PAK4 | 1.68234448 |
| 26 | STK39 | 1.64927308 |
| 27 | EPHB2 | 1.64383510 |
| 28 | MAP3K3 | 1.61966587 |
| 29 | FER | 1.54102892 |
| 30 | LATS1 | 1.49121000 |
| 31 | DAPK2 | 1.42519653 |
| 32 | PTK2 | 1.38755407 |
| 33 | MAP2K3 | 1.33748955 |
| 34 | PRKG2 | 1.30304638 |
| 35 | MAPK15 | 1.30237549 |
| 36 | MAP3K2 | 1.24982222 |
| 37 | ICK | 1.19498397 |
| 38 | GRK5 | 1.18559456 |
| 39 | MAP3K7 | 1.16151519 |
| 40 | FRK | 1.15667860 |
| 41 | CSK | 1.13949735 |
| 42 | PKN2 | 1.12684534 |
| 43 | EEF2K | 1.08240458 |
| 44 | FGFR3 | 1.08034848 |
| 45 | TAOK3 | 1.06545152 |
| 46 | MAP3K9 | 1.06150455 |
| 47 | MYLK | 1.00149088 |
| 48 | ZAP70 | 0.99815835 |
| 49 | TTK | 0.99600442 |
| 50 | CDK12 | 0.99418542 |
| 51 | PRKCI | 0.97752816 |
| 52 | PBK | 0.92349979 |
| 53 | MET | 0.89479282 |
| 54 | MAP2K2 | 0.89396263 |
| 55 | STK38L | 0.87386802 |
| 56 | KDR | 0.84822368 |
| 57 | GSK3A | 0.83803588 |
| 58 | MAP2K6 | 0.83591185 |
| 59 | ERBB2 | 0.82798282 |
| 60 | MATK | 0.80356190 |
| 61 | PDGFRA | 0.80103923 |
| 62 | EPHA3 | 0.78167582 |
| 63 | RPS6KB2 | 0.74257850 |
| 64 | STK24 | 0.73257558 |
| 65 | ERBB4 | 0.72029136 |
| 66 | MAP3K1 | 0.69447597 |
| 67 | SGK3 | 0.68904765 |
| 68 | KSR2 | 0.67790844 |
| 69 | MAP2K4 | 0.67192064 |
| 70 | TYK2 | 0.64703828 |
| 71 | ACVR1B | 0.63437224 |
| 72 | DYRK1B | 0.62854135 |
| 73 | JAK2 | 0.61604954 |
| 74 | TGFBR1 | 0.61297212 |
| 75 | BCR | 0.61273948 |
| 76 | PDPK1 | 0.60739484 |
| 77 | CDK6 | 0.60309977 |
| 78 | MAP3K11 | 0.60269862 |
| 79 | PDGFRB | 0.58917309 |
| 80 | CDC42BPA | 0.57112372 |
| 81 | MAP2K1 | 0.55644700 |
| 82 | TAOK1 | 0.54238294 |
| 83 | PRKD1 | 0.52293201 |
| 84 | EGFR | 0.51576916 |
| 85 | WNK1 | 0.51516779 |
| 86 | INSRR | 0.51076755 |
| 87 | MAPKAPK3 | 0.50163230 |
| 88 | NEK9 | 0.49001006 |
| 89 | MTOR | 0.47485608 |
| 90 | TESK1 | 0.45844848 |
| 91 | MAPK11 | 0.45636689 |
| 92 | PRKAA2 | 0.44822791 |
| 93 | ITK | 0.44641698 |
| 94 | PIK3CA | 0.44061446 |
| 95 | NTRK1 | 0.43878467 |
| 96 | CAMK4 | 0.43251158 |
| 97 | CSF1R | 0.43066895 |
| 98 | SGK223 | 0.43029239 |
| 99 | SGK494 | 0.43029239 |
| 100 | SIK3 | 0.42786019 |
| 101 | NEK2 | 0.41784539 |
| 102 | STK3 | 0.41682752 |
| 103 | TYRO3 | 0.40025792 |
| 104 | JAK1 | 0.40001520 |
| 105 | MAP3K10 | 0.36398885 |
| 106 | MAP3K6 | 0.36103541 |
| 107 | RPS6KA2 | 0.36063601 |
| 108 | TBK1 | 0.35037202 |
| 109 | ABL2 | 0.35010764 |
| 110 | MUSK | 0.34994681 |
| 111 | NEK6 | 0.34211992 |
| 112 | CAMK1D | 0.33091758 |
| 113 | IGF1R | 0.32737737 |
| 114 | MARK2 | 0.32283682 |
| 115 | PRKCZ | 0.31821118 |
| 116 | SGK2 | 0.31565026 |
| 117 | IRAK3 | 0.30691683 |
| 118 | PIK3CG | 0.29006873 |
| 119 | MAPK7 | 0.28676032 |
| 120 | MAP3K12 | 0.28122707 |
| 121 | BMX | 0.28113059 |
| 122 | FGFR1 | 0.28011485 |
| 123 | ADRBK1 | 0.27482374 |
| 124 | STK38 | 0.26454630 |
| 125 | BRSK2 | 0.25827691 |
| 126 | PRKD2 | 0.25592865 |
| 127 | CSNK1A1 | 0.25558691 |
| 128 | FLT3 | 0.24196750 |
| 129 | CHUK | 0.23689753 |
| 130 | SRC | 0.23095752 |
| 131 | TRPM7 | 0.21950523 |
| 132 | DMPK | 0.21928389 |
| 133 | VRK2 | 0.21753855 |
| 134 | PHKG1 | 0.21744118 |
| 135 | PHKG2 | 0.21744118 |
| 136 | IRAK1 | 0.20409897 |
| 137 | PRKCD | 0.20080817 |
| 138 | CDK7 | 0.19240385 |
| 139 | CDK9 | 0.18146549 |
| 140 | HIPK2 | 0.17053889 |
| 141 | MAPKAPK2 | 0.16779190 |
| 142 | ILK | 0.16549052 |
| 143 | CSNK1E | 0.16515051 |
| 144 | MELK | 0.16338170 |
| 145 | NLK | 0.15878753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.42507955 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31039902 |
| 3 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.15446699 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.96747789 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.62542786 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.57907028 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53828263 |
| 8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.51105656 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.48935511 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.47904596 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45586825 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.28384112 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.26913012 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.21413339 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.19284847 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.17254706 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.10681285 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.07748297 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99286083 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.97593363 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.85184013 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.84275388 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82700917 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75878617 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.75605541 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.75103027 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73190133 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71327425 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64495735 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.56921913 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55443871 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53021390 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47004972 |
| 34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.43875512 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43154248 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36459938 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28873408 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26490510 |
| 39 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26422586 |
| 40 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.25718788 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.23757090 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23303846 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22540910 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16225432 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12097442 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09220796 |
| 47 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06968872 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04906174 |
| 49 | Mineral absorption_Homo sapiens_hsa04978 | 1.04894488 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02716898 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99155833 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.96039107 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91872456 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.90767600 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83033985 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82188122 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81826864 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81187821 |
| 59 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.80132282 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79539903 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79128875 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77830026 |
| 63 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75621306 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73778970 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.73750422 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.72967585 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70524954 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70255384 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66520006 |
| 70 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65914908 |
| 71 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63809844 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61475189 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60056130 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58889487 |
| 75 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58364151 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.58276595 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54447158 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54004433 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52199587 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.51449019 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47796093 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46741493 |
| 83 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45875389 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45329465 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.42703742 |
| 86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41730764 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.39636756 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37930830 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37667494 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36784616 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36552814 |
| 92 | Adherens junction_Homo sapiens_hsa04520 | 0.36306770 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34245805 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33831781 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.31966095 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31915642 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30111248 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29854278 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29331563 |
| 100 | Salivary secretion_Homo sapiens_hsa04970 | 0.29230054 |
| 101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28805092 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27744511 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26543750 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26210602 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.25926342 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25499156 |
| 107 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.24668177 |
| 108 | Other glycan degradation_Homo sapiens_hsa00511 | 0.22362924 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22270745 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21901521 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.20454394 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.20265107 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.16566676 |
| 114 | Focal adhesion_Homo sapiens_hsa04510 | 0.14394977 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14374993 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.14182501 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14132027 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.13677093 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11468724 |
| 120 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.10158658 |
| 121 | Pertussis_Homo sapiens_hsa05133 | 0.08824671 |
| 122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.05667649 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.04561310 |

